Giovanni Montini

ORCID: 0000-0002-7350-4475
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pediatric Urology and Nephrology Studies
  • Renal Diseases and Glomerulopathies
  • Urinary Tract Infections Management
  • Urological Disorders and Treatments
  • Dialysis and Renal Disease Management
  • Kidney Stones and Urolithiasis Treatments
  • Renal and related cancers
  • Chronic Kidney Disease and Diabetes
  • Erythropoietin and Anemia Treatment
  • Renal and Vascular Pathologies
  • Neonatal Health and Biochemistry
  • Metabolism and Genetic Disorders
  • Electrolyte and hormonal disorders
  • Iron Metabolism and Disorders
  • Biomedical Research and Pathophysiology
  • Ion Transport and Channel Regulation
  • COVID-19 Clinical Research Studies
  • Complement system in diseases
  • Renal Transplantation Outcomes and Treatments
  • Adolescent and Pediatric Healthcare
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Escherichia coli research studies
  • Coenzyme Q10 studies and effects
  • Pharmacological Effects and Toxicity Studies
  • Acute Kidney Injury Research

University of Milan
2016-2025

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
2016-2025

University of Palermo
2024

Istituti di Ricovero e Cura a Carattere Scientifico
2017-2023

Hacettepe University
2023

University of Genoa
2023

Istituto Giannina Gaslini
2023

Morgan Stanley Children's Hospital
2023

University of Milano-Bicocca
2023

Ospedale Maggiore
1999-2022

OBJECTIVES. Febrile urinary tract infections are common in children and associated with the risk for renal scarring long-term complications. Antimicrobial prophylaxis has been used to reduce recurrence. We performed a study determine whether no is similar antimicrobial 12 months reducing recurrence of febrile after first infection. METHODS. The was controlled, randomized, open-label, 2-armed, noninferiority trial comparing (co-trimoxazole 15 mg/kg per day or co-amoxiclav day) months. A total...

10.1542/peds.2007-3770 article EN PEDIATRICS 2008-10-31

Renal hypodysplasia (RHD) is characterized by a reduced nephron number, small kidney size, and disorganized renal tissue. A hereditary basis has been established for subset of affected patients, suggesting major role developmental genes that are involved in early organogenesis. Gene mutations have dominant inheritance cause RHD, urinary tract anomalies, defined extrarenal symptoms identified TCF2 (renal cysts diabetes syndrome), PAX2 (renal-coloboma EYA1 SIX1 (branchio-oto-renal SALL1...

10.1681/asn.2006030277 article EN Journal of the American Society of Nephrology 2006-09-14

Primary coenzyme Q(10) (CoQ(10)) deficiency includes a group of rare autosomal recessive disorders primarily characterized by neurological and muscular symptoms. Rarely, glomerular involvement has been reported. The COQ2 gene encodes the para-hydroxybenzoate-polyprenyl-transferase enzyme CoQ(10) synthesis pathway. We identified two patients with early-onset lesions that harbored mutations in gene. first patient presented steroid-resistant nephrotic syndrome at age 18 months as result...

10.1681/asn.2006080833 article EN Journal of the American Society of Nephrology 2007-09-14

The efficacy of continuous antibiotic prophylaxis in preventing urinary tract infection (UTI) infants with grade III, IV, or V vesicoureteral reflux is controversial. Download a PDF the Research Summary. In this investigator-initiated, randomized, open-label trial performed 39 European centers, we randomly assigned 1 to 5 months age and no previous UTIs receive (prophylaxis group) treatment (untreated for 24 months. primary outcome was occurrence first UTI during period. Secondary outcomes...

10.1056/nejmoa2300161 article EN New England Journal of Medicine 2023-09-08

<b>Objective</b> To compare the efficacy of oral antibiotic treatment alone with started parenterally and completed orally in children a first episode acute pyelonephritis. <b>Design</b> Multicentre, randomised controlled, open labelled, parallel group, non-inferiority trial. <b>Setting</b> 28 paediatric units north east Italy. <b>Participants</b> 502 aged 1 month to &lt;7 years clinical <b>Intervention</b> Oral co-amoxiclav (50 mg/kg/day three doses for 10 days) or parenteral ceftriaxone...

10.1136/bmj.39244.692442.55 article EN BMJ 2007-07-04

Coenzyme Q10 (CoQ10) deficiency has been associated with various clinical phenotypes, including an infantile multisystem disorder. The authors report a 33-month-old boy who presented corticosteroid-resistant nephrotic syndrome in whom progressive encephalomyopathy later developed. CoQ10 was decreased both muscle and fibroblasts. Oral improved the neurologic picture but not renal dysfunction.

10.1212/01.wnl.0000172859.55579.a7 article EN Neurology 2005-08-23

Abstract The mean annual incidence of hemolytic uremic syndrome in persons <15 years age Italy from 1988 to 2000 was 0.28 per 100,000 population. Laboratory investigations showed that Shiga toxin–producing Escherichia coli (STEC) infection occurred 73.1% patients. STEC O157 the most common serotype, but a considerable number cases were infections by non-O157 STEC.

10.3201/eid0901.020266 article EN cc-by Emerging infectious diseases 2003-01-01

We report the recommendations for diagnosis, treatment, imaging evaluation and use of antibiotic prophylaxis in children with first febrile urinary tract infection, aged 2 months to 3 years. They were prepared by a working group Italian Society Pediatric Nephrology after careful review available literature consensus decision, when clear evidence was not available.These are endorsed Nephrology. can also be tool comparison other existing guidelines issues which much controversy still exists.

10.1111/j.1651-2227.2011.02549.x article EN Acta Paediatrica 2011-11-28

Steroid-dependent nephrotic syndrome (SDNS) carries a high risk of toxicity from steroids or steroid-sparing agents. This open-label, noninferiority, randomized controlled trial at four sites in Italy tested whether rituximab is noninferior to maintaining remission juvenile SDNS. We enrolled children age 1-16 years who had developed SDNS the previous 6-12 months and were maintained with prednisone doses (≥0.7 mg/kg per day). randomly assigned participants continue alone for 1 month (control)...

10.1681/asn.2014080799 article EN Journal of the American Society of Nephrology 2015-01-16

OBJECTIVES. The American Academy of Pediatrics recommendation for febrile infants and young children suspected having a urinary tract infection is early antibiotic treatment, given parenterally if necessary. In support this recommendation, data suggesting that delay in treatment acute pyelonephritis increases the risk kidney damage are cited. Because was not well defined, we investigated renal scarring associated with delayed versus children. METHODS. research findings derived from 2...

10.1542/peds.2007-2894 article EN PEDIATRICS 2008-09-01

OBJECTIVE: To evaluate the yield, economic, and radiation costs of 5 diagnostic algorithms compared with a protocol where all tests are performed (ultrasonography scan, cystography, late technetium99dimercaptosuccinic acid scan) in children after first febrile urinary tract infections. METHODS: A total 304 children, 2 to 36 months age, who completed follow-up (ultrasonography, cystourethrography, acute scans) randomized controlled trial (Italian Renal Infection Study 1) were eligible. The...

10.1542/peds.2012-0164 article EN PEDIATRICS 2013-02-26
Coming Soon ...